Join
Live feed
·
PRReleasevia Quantisnow
MiNK Therapeutics Inc. logo

MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development

ByQuantisnow·Wall Street's wire, on your screen.
INKT· MiNK Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INKT (MiNK Therapeutics Inc.) and more on Quantisnow.